Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: June 17, 2026
Principal Office: Yokne-am Illit, Israel
Context: The filing announces the implementation of a 1-for-3 reverse share split for the Company's ordinary shares and tradable warrants, approved by shareholders on June 4, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions regarding share structure.
| Metric | Pre-Split | Post-Split (Approx.) |
|---|---|---|
| Outstanding Ordinary Shares | 6,568,408 | 2,189,469 |
| Outstanding Warrants | 32,886 | 10,962 |
| Authorized Share Capital | 500,000,000 | 500,000,000 (No adjustment) |
Material Changes
- Share Consolidation: Every three (3) Ordinary Shares and Warrants are consolidated into one (1).
- Exercise Price Adjustment: The exercise price underlying each Warrant is proportionately adjusted.
- Trading Details: Shares and Warrants will trade on a split-adjusted basis on the Nasdaq Capital Market starting June 22, 2026, under existing symbols "WLDS" and "WLDSW".
- CUSIP Updates: New CUSIP numbers are M97838 409 (Shares) and M97838 219 (Warrants).
- Fractional Shares: No fractional shares will be issued; holdings are rounded to the nearest whole share based on a threshold of more than half of a consolidated share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors beyond the mechanics of the split. The primary contingency noted is the rounding of fractional shares, where only shareholders holding fractional consolidated shares of more than half the required amount receive a whole share.
Investor Verification Checklist
- Verify the effective trading date of June 22, 2026, for split-adjusted pricing.
- Confirm the new CUSIP numbers (M97838 409 and M97838 219) with your broker to ensure proper account updates.
- Review the treatment of fractional shares to determine if any holdings will be rounded down to zero.
- Check the adjusted exercise price of any held warrants.
- Confirm that the authorized share capital remains unchanged at 500,000,000 shares.